1.. Introduction {#S1}
================

According to the investigation by The International Diabetes Federation, by the end of 2015, the number of diabetes cases worldwide was as high as 4.15 hundred million, and the prevalence rate was 9.09%. Glucose metabolism disorder is a major clinical manifestation of diabetes \[[@ref001]\]. Epidemiologic evidence has revealed a powerful connection among the blood glucose concentration, cardiovascular disease, arteriosclerosis and mortality \[[@ref002], [@ref003]\]. Additionally, severe glucose metabolism disorder may result in acute complications, such as ketoacidosis and a diabetic hyperglycemic hyperosmolar state (HHS).

An approach to completely cure diabetes has not been discovered. The method to maintain normal blood glucose level in clinic is the frequent detection combined with drug therapy. The finger prick test is most popular blood glucose detection technique \[[@ref004]\], which improves the level of control but has some disadvantages such as infection, invasiveness, high costs etc. It is necessary to develop noninvasive blood glucose method. Near-infrared (NIR) spectroscopy detection technology is one of the promising noninvasive blood glucose detection method because of low costs, high precision and noninvasiveness.

The researchers worldwide pay much attention to NIR noninvasive blood glucose detection technology. For instance, Unnikrishna Menon et al. measured the reflected near-infrared light through the fingertip before and after occluding the blood flow and predicted glucose present in blood \[[@ref005]\]. Yadav et al. designed developed the prototype for near-infrared noninvasive blood glucose detection and claimed that NIR detection technology is promising in noninvasive blood glucose detection \[[@ref006]\].

The precision of the noninvasive blood glucose model is key to clinical application. Chuah et al. collected 290 sets of NIR signals between 1500 nm and 1800 nm and applied the two-stage partial least squares (PLS) regression model to prediction of blood glucose, which reveals that the accuracy of the model is improved \[[@ref007]\]. Yamakoshi et al. collected 100 sets of NIR spectrum data between 900 nm and 1700 nm by spectrograph and considered the Support Vector Machine to be most accurate based on contrast analysis of principle component analysis (PCA), PLS and SVM \[[@ref008]\]. The model combining parallel factor analysis and multiple linear regression is established which is more accurate and robust than multiple linear regression \[[@ref009]\]. Each of the methods has advantages, but has some disadvantages: (1) More independent variables can capture more information while more independent variables would cause information redundancy; (2) Spectrometers with high precision and high speed counteract the promotion of noninvasive blood glucose detection at home; (3) The fundamental concept of NIR noninvasive blood glucose detection technology is the Beer-Lambert law, which is applicable to human tissue under ideal conditions. However, NIR noninvasive blood glucose detection does not exactly agree with the Beer-Lambert law, and the relationship between the NIR signal and blood glucose measurement is both linear and nonlinear; (4) These methods do not consider the difference of individual and daily physiological rule.

Ficorella et al. pointed out that the best performances in terms of sensitivity and resolutions is obtain at 1550 nm \[[@ref010]\]. To reduce the number of independent variables, our research team designed and developed the noninvasive blood glucose detection optical subsystem using 1550-nm NIR spectrum \[[@ref011]\]. The PSO-ANN model is established with considering the nonlinear relationship between blood glucose concentration and 1550-nm absorbance and correcting the individual difference and physiological glucose dynamics. Two artificial neural networks (ANNs) are employed as the basic structure of the PSO-ANN model, and the weight coefficients of the two ANNs which represent the difference of individual and daily physiological rule are optimized by particle swarm optimization (PSO).

Figure 1.The system structure diagram.

2.. Materials and methods {#S2}
=========================

2.1. Collection of experimental data {#S2.SS1}
------------------------------------

The 1550-nm NIR signal is measured by the noninvasive blood glucose detection optical subsystem developed by our research group, whose structure is shown in Fig. [1](#thc-26-thc174592-g001){ref-type="fig"}. The 1550-nm NIR signal carries the human blood glucose concentration information \[[@ref011]\]. The measurement of the blood glucose concentration is minimally invasive, so the volunteers are informed of the specific process and risk before the experiment, and the data collection was performed with the volunteers' consent, which meets ethical standards. *One touch Ultra Easy* (paired with *one touch Sure Step* Test Strips) is employed to measure the blood glucose concentration. The experimental procedure was as follows: (1) Turn on the power of the optical subsystem and adjust it to the ready position; (2) Wash the volunteer's hand with soap and spread the hand out to dry; (3) Place the left index finger in the testing room in gentle contact with the surface of the collimator. Control the collection of the data using the experimental system software, and obtain the 1550-nm NIR signal; (4) Repeat step 3 three times to record the 1550-nm NIR signals and take the average of the three measurements; (5) Sterilize the finger with 75% alcohol and measure the blood glucose concentration using the *one touch Ultra Easy* and test strip after the alcohol fully evaporates; (6) Record the blood glucose measurement values.

Finally, 14 datasets were collected. In which, the 1$^{\text{st}}$ dataset (data_1) contains 6 data, the 2$^{\text{nd}}$ dataset (data_2) contains 6 data, the 3$^{\text{rd}}$ dataset (data_3) contains 5 data, the 4$^{\text{th}}$ dataset (data_4) contains 6 data, the 5$^{\text{th}}$ dataset (data_5) contains 6 data, the 6$^{\text{th}}$ dataset (data_6) contains 6 data, the 7$^{\text{th}}$ dataset (data_7) contains 6 data, the 8$^{\text{th}}$ dataset (data_8) contains 3 data, the 9$^{\text{th}}$ dataset (data_9) contains 9 data, the 10$^{\text{th}}$ dataset (data_10) contains 9 data, the 11$^{\text{th}}$ dataset (data_11) contains 8 data, the 12$^{\text{th}}$ dataset (data_12) contains 9 data, the 13$^{\text{th}}$ dataset (data_13) contains 6 data, and the 14$^{\text{th}}$ dataset (data_14) contains 8 data. The data includes 1550-nm NIR signals and blood glucose concentration.

2.2. Model evaluation indexes {#S2.SS2}
-----------------------------

### 2.2.1. Root-mean-square error {#S2.SS2.SSS1}

The root-mean-square error (RMSE) is the square root of the ratio of the sum of the squared deviation between the prediction values and the measurement values divided by the sample size. The formula is as follows:

$$\text{RMSE} = \sqrt{\frac{\sum_{i = 1}^{N}{({y_{i} - \hat{y_{i}}})}^{2}}{N}}$$

$N$ is the sample size, $y_{i}$ is the measurement value, and $\hat{y_{i}}$ is the prediction value.

### 2.2.2. Relative error rate {#S2.SS2.SSS2}

The relative error rate (RER) is the ratio of the absolute error between the prediction values and measurement values to the measurement values; the formula is as follows:

$$\text{RER} = {\frac{y_{i} - \hat{y_{i}}}{y_{i}} \times {100\%}}$$

### 2.2.3. Correlation coefficient {#S2.SS2.SSS3}

The correlation coefficient is the ratio of the covariance between the prediction values and measurement values to the product of the standard deviations, and the formula is as follows:

$$r = \frac{\sum_{i = 1}^{N}{{({y_{i} - \overline{y}})}{({\hat{y_{i}} - \overline{\hat{y}}})}}}{\sum_{i = 1}^{N}{{({y_{i} - \overline{y}})}^{2} \cdot {\sum_{i = 1}^{N}{({\hat{y_{i}} - \overline{\hat{y}}})}^{2}}}}$$

$\overline{y}$ is the mean of the measurement values, and $\overline{\hat{y}}$ is the mean of the prediction values. The correlation coefficient is an important indicator of the correlation between the two variances, but the method can often be misled by spurious correlations, especially in the presence of nonlinearities. Thus, the conclusion may be inaccurate if the evaluating effect of the correlation coefficient is overemphasized. This thesis only considers the correlation coefficient as an auxiliary indicator.

2.3. Theory of the ANN model {#S2.SS3}
----------------------------

As described in part 1, there is nonlinear relationship between blood glucose concentration and corresponding NIR absorbance. The artificial neural network (ANN) not only delineates linear relationship but also nonlinear relationship \[[@ref012]\], so the model incorporating ANN can be established, which consists of the input layer, hidden layer and output layer.

2.4. Theory of the PSO-2ANN model {#S2.SS4}
---------------------------------

The ANN model could capture the nonlinear relationship between blood glucose concentration and 1550-nm NIR absorbance, but the ANN model with stationary structure and certain parameters fails to show adequate predictive ability to the new datasets. Generally, the noninvasive blood glucose detection model need to be corrected on account for individual difference (such as skin color) and physiological glucose dynamics. There are many parameters to be corrected in the ANN model, which hinder the household promotion of noninvasive blood glucose measurement. To overcome the above shortcomings, the PSO-2ANN model is proposed. The PSO-ANN model is established with considering the nonlinear relationship between blood glucose concentration and 1550-nm absorbance and correcting the individual difference and physiological glucose dynamics. Two artificial neural networks (ANNs) with stationary structure and certain parameters are employed as the basic structure of the PSO-ANN model, and the weight coefficients of the two ANNs which represent the individual difference and physiological glucose dynamics are optimized by particle swarm optimization (PSO) \[[@ref013]\].

3.. Results {#S3}
===========

3.1. The ANN model {#S3.SS1}
------------------

### 3.1.1. Construction of the ANN model {#S3.SS1.SSS1}

Fourteen datasets were obtained during the experiment. The three nets were established by 3 datasets (data_9, data_10, data_12), whose sample sizes are large to provide more information. To improve the performance of the nets, the three nets were trained with the 1550-nm NIR signal (denoted by PD) and the reciprocal of the signal (denoted by 1/PD) as independent variables and blood glucose concentrations as dependent variables. The full process is described below.

(1)Determination of the input neurons and the output neurons: Because there is 1 independent variable and 1 dependent variable, there is 1 neuron in both the input layer and the output layer.(2)Determination of the hidden neurons: The number of the hidden neurons is determined by synthetically considering the RMSE of every dataset and the complexity of the model.

Table 1RMSEs of Net11, Net12 and Net13 (the independent variable is PD)Number of the hidden neuronsNet11Net12Net1310.403560.537721.1149220.189440.537721.0703730.161510.251810.1594340.145482.08E$-$162.17E$-$0250.140322.19E$-$161.29E$-$2469.65E$-$153.76E$-$163.32E$-$2672.73E$-$181.67E$-$214.80E$-$2585.07E$-$191.87E$-$219.13E$-$2492.77E$-$191.47E$-$243.06E$-$24101.05E$-$253.66E$-$214.16E$-$16

Table [1](#T1){ref-type="table"} shows the RMSEs of three nets with different numbers of the hidden neurons, whose independent variable is PD. The data in column 2 indicate that the variation trend of the RMSEs of Net11 is small when the number of the hidden neurons is greater than 6; the data in column 3 and column 4 were similarly analyzed. The final numbers of the hidden neurons of Net11, Net12 and Net13 were consistently set at 6 to facilitate the comparison of parameters.

As above, the numbers of the hidden neurons of Net21, Net22 and Net23, whose independent variable is 1/PD, were consistently set at 5.

The structures of Net11, Net12, Net13, Net21, Net22 and Net23 were determined after the numbers of the input neurons, the hidden neurons and the output neurons were confirmed. IHW, Hb, HOW, and Ob represent the weight coefficients of the input layer to the hidden layer, the thresholds of the hidden layer, the weight coefficients of the hidden layer to the output layer and the thresholds of the output layer. After trained by the Neural Net Fitting application in MATLAB R2014a, the parameters of Net11, Net12 and Net13 are given in Table [2](#T2){ref-type="table"}. Net21, Net22 and Net23 are similar, so we won't cover those again.

### 3.1.2. Evaluation of the ANN model {#S3.SS1.SSS2}

After establishing of Net11, Net12, Net13, Net21, Net22 and Net23, the performance of the ANN model was evaluated by using the following indexes with 14 datasets as the test data.

*3.1.2.1. RMSE and correlation coefficient ($p$)*

First, based on the respective analysis of each network, this study found that the prediction performance of the 6 networks is poor for new datasets, illustrating that the ANN model lacks robustness. Next, ANN with 1/PD as the independent variable is more accurate than ANN with PD as the independent variable, as revealed by separately comparing Net11 and Net21, Net12 and Net22, and Net13 and Net23.

Table 2Parameters of Net11, Net12 and Net13 (the independent variable is PD)Net11Net12Net13IHWHbHOWObIHWHbHOWObIHWHbHOWOb7.73$-$9.08$-$4.113.23$-$9.097.732.360.83$-$8.518.290.620.018.48$-$4.94$-$0.02--$-$10.935.46$-$4.68--$-$8.434.950.33--$-$8.431.25$-$0.69--$-$17.144.11$-$4.23--$-$8.361.76$-$1.06--$-$21.60$-$19.78$-$17.28--6.39$-$1.80$-$6.98--$-$8.21$-$6.682.05--$-$34.18$-$30.839.78--8.647.072.83--20.3517.125.10--$-$9.64$-$9.6115.17$-$8.88$-$8.452.64$-$19.60$-$16.963.96

Table 3Comparative analysis of RMSE and $p$NetworkIndependent variable is PDIndependent variable is 1/PDNet11Net12Net13Net21Net22Net23RMSE$p$RMSE$p$RMSE$p$RMSE$p$RMSE$p$RMSE$p$data_19.390.312.860.361.22NaN1.67$-$0.312.85$-$0.190.53$-$0.22data_210.04$-$0.302.26$-$0.310.80NaN2.240.112.25$-$0.020.800.00data_39.270.553.150.561.65NaN1.760.113.150.321.100.28data_410.23$-$0.362.09NaN0.72NaN3.14$-$0.322.08$-$0.300.93$-$0.30data_52.730.691.910.863.530.791.490.880.790.743.370.70data_610.11$-$0.332.27NaN0.92NaN3.63$-$0.522.26$-$0.390.97$-$0.40data_70.750.233.08$-$0.290.88$-$0.741.140.911.790.570.97$-$0.40data_81.11$-$0.820.990.943.720.991.230.890.950.983.691.00data_90.001.001.450.121.850.360.001.001.25$-$0.222.120.17data_102.780.560.001.001.93$-$0.272.670.560.001.002.46$-$0.30data_111.770.071.970.302.050.101.960.181.810.412.400.21data_121.950.062.51$-$0.200.001.002.45$-$0.252.56$-$0.160.001.00data_131.95$-$0.171.51$-$0.142.070.841.63$-$0.421.20$-$0.542.070.91data_141.740.084.01$-$0.012.110.172.46$-$0.182.070.122.34$-$0.04Note: NaN in Table [3](#T3){ref-type="table"} occurs when the denominator in the formula of the correlation coefficient is zero, which is meaningless.

Table 4Analysis of the relative errorNetworkIndependent variable is PDIndependent variable is 1/PDNet11Net12Net13Net21Net22Net23data_178.22%23.80%10.18%13.95%23.76%4.39%data_283.70%18.80%6.63%18.67%18.76%6.67%data_377.27%26.25%13.74%14.68%26.21%9.14%data_485.23%17.38%5.97%26.21%17.33%7.75%data_522.73%15.90%29.45%12.40%6.56%28.09%data_684.22%18.89%7.67%30.29%18.84%8.11%data_76.27%25.68%7.30%9.53%14.91%8.06%data_89.22%8.25%30.99%10.28%7.93%30.79%data_9--12.05%15.44%--10.41%17.64%data_109.83%--16.07%8.94%--19.64%data_1114.72%16.41%17.07%16.37%15.07%19.99%data_1216.25%20.88%--20.42%21.30%--data_1316.29%12.57%17.27%13.54%9.98%17.23%data_1414.49%33.43%17.57%20.53%17.27%19.53%

*3.1.2.2. RER*

The data in Table [4](#T4){ref-type="table"} show that prediction precision of the 6 networks is low. The ANN with 1/PD as the independent variable is more accurate than the ANN with PD as the independent variable based on separate comparisons of Net11 and Net21, Net12 and Net22, and Net13 and Net23, in agreement with the results above.

*3.1.2.3. EGA*

Clarke error grid analysis (EGA) is the "gold standard" and considers 4 factors -- the absolute prediction values of blood glucose, the absolute deviation between the predictions and measurements, the relative difference in those deviations, and the clinical significance of the difference \[[@ref014]\]. Clinically, the values distributed in regions A and B are acceptable, while the values distributed in other regions are not acceptable. The EGAs are illustrated by Net12 and Net22 to comparatively analyze. Figure [2](#thc-26-thc174592-g002){ref-type="fig"} shows that the predictions of Net12 are distributed in regions A, B, C and D, while the predictions of Net22 are distributed in regions A, B and D. The percentage of each region in the EGA is presented in Table [5](#T5){ref-type="table"} for a clear comparative analysis. The ANN model could not make all predictions distributed in regions A and B. The ANN with 1/PD as the independent variable was more accurate. Thus, 1/PD will be subsequently used as the independent variable.

Table 5Statistical table of Clarke error grid analysisNetworksIndependent variable is PDIndependent variable is 1/PDNet11Net12Net13Net21Net22Net23A67.74%37.63%53.76%39.78%45.16%53.76%B26.88%56.99%41.94%59.14%50.54%41.94%C1.08%1.08%0.00%1.08%0.00%0.00%D4.30%4.30%4.30%0.00%4.30%4.30%E0.00%0.00%0.00%0.00%0.00%0.00%

Figure 2.Clarke error grid Analysis of Net12 and Net22.

3.2. The PSO-2ANN model {#S3.SS2}
-----------------------

### 3.2.1. Construction of the PSO-2ANN model {#S3.SS2.SSS1}

The two nets that are more accurate among Net21, Net22, and Net23 trained with 1/PD as an independent variable were taken as submodules, and the weight coefficients of the two were optimized by PSO. The algorithm process of the PSO-2ANN model is as follows: (1) Selection of submodules: The data in Tables [3](#T3){ref-type="table"} and [4](#T4){ref-type="table"} reveals that the prediction performance of Net22 is worse for all experimental datasets; thus the two submodules were Net21 and Net23; (2) Topological structure of PSO-2ANN: Net21 and Net23 are two submodules of the PSO-2ANN model, denoted by Net, Net $=$ a1 $\ast$ Net21 $+$ (1 $-$ a1) $\ast$ Net23; (3) Optimization of parameter a1: The RMSE between the measurements and the predictions of blood glucose is the objective function. The parameter a1 is the position vector of the particle whose solution space is between 0 and 1. The new position vector of the particle is determined by its experience and information shared by other particles. The first data in every dataset is used as the training data, while the remainder are used as the testing data.

Table 6Evaluation indicators of PSO-2ANNDatasetRMSERER$P$data_10.695.73%$-$0.26data_20.887.31%0.46data_31.3911.58%0.04data_41.058.73%$-$0.39data_51.5112.55%0.88data_61.068.82%$-$0.54data_70.967.99%$-$0.32data_81.2910.78%1.00data_90.020.16%1.00data_101.038.57%0.47data_111.7714.77%0.18data_120.080.68%1.00data_131.2210.18%0.57data_142.2618.87%$-$0.23

Figure 3.Clarke error grid of PSO-2ANN.

### 3.2.2. Evaluation of the PSO-ANN model {#S3.SS2.SSS2}

*3.2.2.1. RMSE, RER and $p$*

The performance of the PSO-2ANN model was superior to that of the ANN model whether evaluated by RMSE, RER or p based on a comparative analysis, as shown in Tables [3](#T3){ref-type="table"}, [4](#T4){ref-type="table"} and [6](#T6){ref-type="table"}. Additionally, the PSO-2ANN model is capable to overcome individual difference and physiological glucose dynamics.

*3.2.2.2. EGA*

Figure [3](#thc-26-thc174592-g003){ref-type="fig"} presents the Clarke error grid of the PSO-2ANN model. The percentage of the predictions distributed in region A is 64%, the percentage of the predictions distributed in region B is 29%, and the percentage of the predictions distributed in the critical line between regions A and D is 7%. According to the results of statistical analysis, the predictors of PSO-2ANN meet the clinical accuracy requirement.

Figure 4.RMSEs of 10 experiments.

Figure 5.Bland-Altman plot for predictions and measurements of blood glucose.

3.3. Reliability of the PSO-2ANN model {#S3.SS3}
--------------------------------------

### 3.3.1. Assessment of chance correlation {#S3.SS3.SSS1}

Zhao of Tianjin University indicated that chance correlation may occur during blood glucose modeling \[[@ref015]\]. To further verify the validity and reliability of the PSO-2ANN model, the research on chance correlation during PSO-2ANN modeling was conducted by random number methods. Because the range of experimental data was from 0 to 25, the 1000 $\times$ random number matrix was generated by the function *rand* in MATLAB R2014a, denoted by A. The optimal parameter a1 was obtained by training with A (1:100,1) as the input vector and A (1:100,2) as the target output of PSO-2ANN; the remainder of the matrix was used as the testing set. This experiment was repeated 10 times with RMSE as the evaluation indicator. Figure [4](#thc-26-thc174592-g004){ref-type="fig"} shows that the existing probability of chance correlation in the noninvasive blood glucose model based on PSO-2ANN is small, implying that PSO-2ANN has high reliability.

### 3.3.2. Bland-Altman analysis {#S3.SS3.SSS2}

The Bland-Altman method is the popular method to assess the agreement of medical instruments \[[@ref016]\]. The results of Bland-Altman analysis between predictions by the PSO-2ANN model and measurements are shown in Fig. [5](#thc-26-thc174592-g005){ref-type="fig"}. The mean and the standard deviation of the difference between predictions and measurements are 0.0678 mmol/L and 1.1497 mmol/L, respectively. The 95% limits of agreement are \[$-$2.1856 mmol/L, 2.3212 mmol/L\]. 95.7% of the points fell within the 95% limits of agreement, which was clinically acceptable.

4.. Discussion {#S4}
==============

As shown above, the PSO-2ANN model is capable of noninvasive blood glucose detection by using an invasive blood glucose concentration to calibrate the weight coefficient every day. The enhanced robustness provided by the PSO-2ANN model can be attributed to two primary factors. First, the relationship between blood glucose concentration and 1550-nm absorbance may be different due to individual difference (such as skin color). The two ANNs with different structure and parameters are employed as the submodules of the PSO-2ANN model, which could provide different relationship between blood glucose concentration and 1550-nm absorbance. Second, each ANN model is trained by the dataset on different days which learn the rule of physiological glucose dynamics.

Finally, it should be noted that although application of the PSO-2ANN model enhances prediction accuracy and robustness, it suffers from some drawbacks. First, the experimental datasets are from 6 healthy subjects, the range of which is narrow. thus, the applicability of PSO-2ANN in diabetics needs to be further verified. Second, the blood glucose concentration is impacted by many factors, such as the ambient temperature, pulse rate, blood pressure and finger temperature. The study only considers the 1550-nm absorbance.

5.. Conclusion {#S5}
==============

The 1550-nm NIR signal is employed to predict glucose concentration in blood due to its sensitivity and resolutions to blood glucose. The presence of nonlinear relationship between blood glucose concentration and 1550-nm absorbance must be considered in developing an accurate and robust NIR-based calibration model for predicting blood glucose concentrations. The ANN model can describe the nonlinear relationship but fails to predict new datasets, so the ANN models are taken as the submodules of the PSO-2ANN model, which can overcome individual difference and physiological glucose dynamics. Compared to the ANN model, the PSO-2ANN model can provide the enhanced robustness.
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